Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
Crouse JR 3rd, Bots ML, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Raichlen JS; METEOR Study Group. Crouse JR 3rd, et al. Among authors: evans gw. Eur J Cardiovasc Prev Rehabil. 2010 Apr;17(2):223-9. doi: 10.1097/HJR.0b013e3283359c38. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20038840 Clinical Trial.
Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.
Crouse JR 3rd, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS; Measuring Effects on intima media Thickness: an Evalution Of Rosuvastatin study group. Crouse JR 3rd, et al. Among authors: evans gw. Cardiovasc Drugs Ther. 2004 May;18(3):231-8. doi: 10.1023/B:CARD.0000033645.55138.3d. Cardiovasc Drugs Ther. 2004. PMID: 15229392 Clinical Trial.
360 results